Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

J Pediatr. 2007 Aug;151(2):134-9, 139.e1. Epub 2007 Jun 22.

PMID:
17643762
2.

Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.

Gordon CM, Binello E, LeBoff MS, Wohl ME, Rosen CJ, Colin AA.

Osteoporos Int. 2006;17(5):783-90. Epub 2006 Mar 16.

3.

Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.

Konstan MW, Stern RC, Trout JR, Sherman JM, Eigen H, Wagener JS, Duggan C, Wohl ME, Colin P.

Aliment Pharmacol Ther. 2004 Dec;20(11-12):1365-71.

4.

Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis.

Ordoñez CL, Kartashov AI, Wohl ME.

J Pediatr. 2004 Nov;145(5):689-92.

PMID:
15520781
5.

Flexible prescription assistance program for patients with cystic fibrosis.

Hilmas E, Black J, Gagliano R, Henderson D, Long S, Rosenstein B, Wohl ME.

Am J Health Syst Pharm. 2004 Aug 1;61(15):1590-3. No abstract available.

PMID:
15372833
6.

Pulmonary exacerbations in cystic fibrosis.

Rabin HR, Butler SM, Wohl ME, Geller DE, Colin AA, Schidlow DV, Johnson CA, Konstan MW, Regelmann WE; Epidemiologic Study of Cystic Fibrosis.

Pediatr Pulmonol. 2004 May;37(5):400-6.

PMID:
15095322
7.

Maximal expiratory flow at FRC (V'maxFRC): Methods of selection and differences in reported values.

Koumbourlis AC, Chen XC, Rao JS, Schluchter MD, Easley K, Colin AA, Hiatt P, Kattan M, McCarthy K, Mellins RB, Peavy H, Platzker AC, Steinbach S, Ting A, Weisner MD, Wohl ME; Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodificiency Virus (P2C2HIV) Study Group; National Heart, Lung and Blood Institute.

Pediatr Pulmonol. 2004 Apr;37(4):318-23.

8.

Treatment of acute bronchiolitis.

Wohl ME, Chernick V.

N Engl J Med. 2003 Jul 3;349(1):82-3. No abstract available.

PMID:
12840097
9.

Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis.

Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

J Pediatr. 2003 Jun;142(6):624-30.

PMID:
12838189
10.

Factors influencing outcomes in cystic fibrosis: a center-based analysis.

Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME.

Chest. 2003 Jan;123(1):20-7.

PMID:
12527598
11.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW; Pulmozyme Early Intervention Trial Study Group.

J Pediatr. 2001 Dec;139(6):813-20.

PMID:
11743506
12.

Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).

Romero-Steiner S, Fernandez J, Biltoft C, Wohl ME, Sanchez J, Feris J, Balter S, Levine OS, Carlone GM.

Clin Diagn Lab Immunol. 2001 Nov;8(6):1115-9.

13.

Respiratory diseases in the first year of life in children born to HIV-1-infected women.

Kattan M, Platzker A, Mellins RB, Schluchter MD, Chen XC, Peavy H, Steinbach S, Wohl ME, Hiatt P, Hunter J, Colin AA.

Pediatr Pulmonol. 2001 Apr;31(4):267-76.

PMID:
11288208
14.

Forced expiratory flow in uninfected infants and children born to HIV-infected mothers.

Colin AA, Sunil Rao J, Chen XC, Hunter JM, Hanrahan J, Hiatt P, Kattan M, Koumbourlis A, Mellins RB, Peavy HH, Platzker A, Ting A, Steinbach S, Wohl ME; Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Study Group, National Heart, Lung, and Blood Institute.

Am J Respir Crit Care Med. 2001 Mar;163(4):865-73.

PMID:
11282758
15.

Asthma, steroids, and growth.

Wohl ME, Majzoub JA.

N Engl J Med. 2000 Oct 12;343(15):1113-4. No abstract available.

PMID:
11027747
16.

Thoracoabdominal compression and respiratory system compliance in HIV-infected infants.

Platzker AC, Colin AA, Chen XC, Hiatt P, Hunter J, Koumbourlis AC, Schluchter MD, Ting A, Wohl ME.

Am J Respir Crit Care Med. 2000 May;161(5):1567-71.

PMID:
10806156
17.

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada.

Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, Konstan MW, Light MJ, Rabin HR, Regelmann WE, Schidlow DV, Stokes DC, Wohl ME, Kaplowitz H, Wyatt MM, Stryker S.

Pediatr Pulmonol. 1999 Oct;28(4):231-41.

PMID:
10497371
18.

Cystic fibrosis: predictors of accelerated decline and distribution of disease in 230 patients.

Cleveland RH, Neish AS, Zurakowski D, Nichols DP, Wohl ME, Colin AA.

AJR Am J Roentgenol. 1998 Nov;171(5):1311-5.

PMID:
9798870
19.

Cystic fibrosis: a system for assessing and predicting progression.

Cleveland RH, Neish AS, Zurakowski D, Nichols DP, Wohl ME, Colin AA.

AJR Am J Roentgenol. 1998 Apr;170(4):1067-72.

PMID:
9530060
20.

Inhibition of neutrophil elastase in CF sputum by L-658,758.

Rees DD, Brain JD, Wohl ME, Humes JL, Mumford RA.

J Pharmacol Exp Ther. 1997 Dec;283(3):1201-6.

PMID:
9399994
21.

End-of-life care in cystic fibrosis.

Robinson WM, Ravilly S, Berde C, Wohl ME.

Pediatrics. 1997 Aug;100(2 Pt 1):205-9.

PMID:
9240800
22.

Safety of repeated intermittent courses of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Eisenberg JD, Aitken ML, Dorkin HL, Harwood IR, Ramsey BW, Schidlow DV, Wilmott RW, Wohl ME, Fuchs HJ, Christiansen DH, Smith AL.

J Pediatr. 1997 Jul;131(1 Pt 1):118-24.

PMID:
9255202
23.

The preservation of function: treatment of new acquisition of a pathogen.

Rabin HR, Wohl ME.

Pediatr Pulmonol. 1997 May;23(5):323-4. Review. No abstract available.

PMID:
9168503
24.

Chronic pain in cystic fibrosis.

Ravilly S, Robinson W, Suresh S, Wohl ME, Berde CB.

Pediatrics. 1996 Oct;98(4 Pt 1):741-7.

PMID:
8885955
25.

The effect of the absence of abdominal muscles on pulmonary function and exercise.

Ewig JM, Griscom NT, Wohl ME.

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1314-21.

PMID:
8616560
26.

Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease.

Sheils CA, Käs J, Travassos W, Allen PG, Janmey PA, Wohl ME, Stossel TP.

Am J Pathol. 1996 Mar;148(3):919-27.

27.

Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses.

Shamberger RC, Holzman RS, Griscom NT, Tarbell NJ, Weinstein HJ, Wohl ME.

Surgery. 1995 Sep;118(3):468-71.

PMID:
7652680
28.

Pulmonary sequelae of insults to the lung in early life.

Wohl ME.

Pediatr Pulmonol. 1995 Feb;19(2):90-5. No abstract available.

PMID:
7659471
29.

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.

Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.

N Engl J Med. 1994 Sep 8;331(10):637-42.

30.

Cystic fibrosis.

Colin AA, Wohl ME.

Pediatr Rev. 1994 May;15(5):192-200. Review. No abstract available.

PMID:
8036195
31.

Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin.

Vasconcellos CA, Allen PG, Wohl ME, Drazen JM, Janmey PA, Stossel TP.

Science. 1994 Feb 18;263(5149):969-71.

PMID:
8310295
32.

Pneumatocele complicating hyperimmunoglobulin E syndrome (Job's Syndrome).

Shamberger RC, Wohl ME, Perez-Atayde A, Hendren WH.

Ann Thorac Surg. 1992 Dec;54(6):1206-8. Review.

PMID:
1449312
33.

Spinal fusion in Duchenne muscular dystrophy: a multidisciplinary approach.

Shapiro F, Sethna N, Colan S, Wohl ME, Specht L.

Muscle Nerve. 1992 May;15(5):604-14.

PMID:
1584253
34.

Nonhomogeneous lung emptying in cystic fibrosis patients. Volume history and bronchodilator effects.

Zinman R, Wohl ME, Ingram RH Jr.

Am Rev Respir Dis. 1991 Jun;143(6):1257-61.

PMID:
2048809
35.

Bronchopulmonary dysplasia in adulthood.

Wohl ME.

N Engl J Med. 1990 Dec 27;323(26):1834-6. No abstract available.

PMID:
2247122
36.

The lungs and airways in achondroplasia. Do little people have little lungs?

Stokes DC, Wohl ME, Wise RA, Pyeritz RE, Fairclough DL.

Chest. 1990 Jul;98(1):145-52.

PMID:
2361382
37.

Changes in the contribution of the rib cage to tidal breathing during infancy.

Hershenson MB, Colin AA, Wohl ME, Stark AR.

Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):922-5.

PMID:
2139308
38.

Changes of time constants during infancy and early childhood.

Ratjen FA, Colin AA, Stark AR, Mead J, Wohl ME.

J Appl Physiol (1985). 1989 Nov;67(5):2112-5.

PMID:
2600037
39.

Transition from dynamically maintained to relaxed end-expiratory volume in human infants.

Colin AA, Wohl ME, Mead J, Ratjen FA, Glass G, Stark AR.

J Appl Physiol (1985). 1989 Nov;67(5):2107-11.

PMID:
2600036
40.

A new technique to demonstrate flow limitation in partial expiratory flow-volume curves in infants.

Ratjen F, Zinman R, Wohl ME.

J Appl Physiol (1985). 1989 Oct;67(4):1662-9.

PMID:
2793766
41.

Effect of changes in lung volume on respiratory system compliance in newborn infants.

Ratjen F, Zinman R, Stark AR, Leszczynski LE, Wohl ME.

J Appl Physiol (1985). 1989 Sep;67(3):1192-7.

PMID:
2793712
42.

Bronchopulmonary dysplasia: radiographic appearance in middle childhood.

Griscom NT, Wheeler WB, Sweezey NB, Kim YC, Lindsey JC, Wohl ME.

Radiology. 1989 Jun;171(3):811-4.

PMID:
2717757
43.

Diaphragmatic excursion after pleural sclerosis.

Loring SH, Kurachek SC, Wohl ME.

Chest. 1989 Feb;95(2):374-8.

PMID:
2644090
44.

Dimensions of the trachea to age 6 years related to height.

Griscom NT, Wohl ME, Fenton T.

Pediatr Pulmonol. 1989;6(3):186-90.

PMID:
2717243
45.

Controversies in pediatric pulmonary medicine: infant pulmonary function tests.

Wall M, Coates A, Buist S, Stocks J, England S, Wohl ME, Taussig L.

Am Rev Respir Dis. 1988 Oct;138(4):1069. No abstract available.

PMID:
3202439
46.

Thoracic gas volume in rabbits by low-frequency ambient pressure changes.

Lyttle BD, Duvivier C, Glass GM, Wohl ME, Fredberg JJ.

J Appl Physiol (1985). 1988 Sep;65(3):1444-8.

PMID:
3182512
47.

Relationship between maximal expiratory flows and lung volumes in growing humans.

Martin TR, Feldman HA, Fredberg JJ, Castile RG, Mead J, Wohl ME.

J Appl Physiol (1985). 1988 Aug;65(2):822-8.

PMID:
3170432
48.

In vivo estimation of tracheal distensibility and hysteresis in normal adults.

Hoffstein V, Castile RG, O'Donnell CR, Glass GM, Strieder DJ, Wohl ME, Fredberg JJ.

J Appl Physiol (1985). 1987 Dec;63(6):2482-9.

PMID:
3436880
49.

Airway size is related to sex but not lung size in normal adults.

Martin TR, Castile RG, Fredberg JJ, Wohl ME, Mead J.

J Appl Physiol (1985). 1987 Nov;63(5):2042-7.

PMID:
3693235
50.

Results of surgical treatment of adults with idiopathic scoliosis.

Sponseller PD, Cohen MS, Nachemson AL, Hall JE, Wohl ME.

J Bone Joint Surg Am. 1987 Jun;69(5):667-75.

PMID:
3597465

Supplemental Content

Support Center